Subscribe to Search results

NICE guidelines on Tranexamic acid use was published.

Published on:

NICE Quality Standard on Blood Transfusion was published.

Published on:

There was mandatory training of a maximum of seven years and all doctors had to be on the GMC register of specialists before being able to take up a substantive consultant post

Published on:

Dr Richard Aach commented on the report of the TTV study group: "the evidence was predictive rather than absolute - the same type of evidence that served as a basis for adoption of routine testing of donors for HBsAg in order to reduce Type B hepatitis transmission by transfusion".

Published on:

At a meeting of the ACVSB Group meeting it was stated that anti-HBc testing alone was insufficient to eradicate post-transfusion hepatitis.

Published on:

In a press conference, Professor Gallo termed the virus that caused AIDS "HTLV-III", despite evidence that it was an HTLV virus being tenuous.

Published on:

Following Professor Gallo's HTLV-3 press conference, the US Secretary of State for Health predicted there would be a test to screen blood widely available within six months.

Published on:

Five pharmaceutical companies in the US were chosen to manufacture AIDS blood tests.

Published on:

Professor Weiss wrote an article on AIDS in Nature, which stated that there was no longer any doubt that AIDS was caused by an infectious agent and emphasised that ELISA screening tests for blood supplies were "urgently needed".

Published on:

Dr Gunson reported that a HTLV-3 test produced by Dr Tedder and Professor Weiss would be available within the foreseeable future and the Blood Transfusion Service had agreed at a meeting with Dr Tedder that it would start appraisal of their test as soon as possible. Dr Gunson also anticipated that a major decision to proceed to routine screening of all blood would be required.

Published on:

Professor Tedder stated that various UK HIV tests were available by mid July 1984. However, though these were in used in laboratories, there was little widespread knowledge of this at the time.

Published on:

Professor Tedder stated he aimed to produce a competitive test that was one step instead of two.

Published on:

Professor Tedder told the Inquiry that despite being advised differently, Porton Down decided to develop an antigen using an alternative and unsuccessful method.

Published on:

In a letter from Dr Fraser to Dr Smithies, it was stated that a screening test for AIDS would likely be available within the next 8 weeks and the implications of instituting a testing regime suggested there was an urgent need for a working party on AIDS.

Published on:

At a Scottish National Blood Transfusion Service meeting, directors proposed a UK-wide working group on AIDS and said that such a group should be encouraged to mount donor screening studies.

Published on:

In a letter to the Scottish Home and Health Department, Dr Cash conveyed the views of Scottish National Blood Transfusion Service directors that there should be a UK-wide working group on blood transfusion and AIDs.

Published on:

In an internal minute within the Department of Health and Social Security, Dr Smithies called for an invited group of experts to plan ahead to give guidance to health authorities about the consequences of being able to screen for AIDS. It was planned to start screening all blood donors at the North London RTC in October 1984.

Published on:

A paper was produced by the Department of Health and Social Security titled "Aids Immune Deficiency Syndrome [AIDS] - Current Developments". It highlighted that fewer than 20% of patients had survived more than 2 years after AIDS had been diagnosed, that the number suffering was expected to double within 6 months, and the importance of a screening test for the UK National Blood Transfusion Service.

Published on:

At the internal Department of Health and Social Security meeting, it was agreed that ministers should be made aware of the screening of all donors at the North West London RTC, proposed to start in October, the need for funding to scale up the production of the test reagent, and the further need to set up a working group.

Published on:

In a briefing note, Lord Glenarthur wrote that the UK HTLV-3 screening test developed by Dr Weiss and Dr Tedder was regarded as more sensitive, specific, and possibly more reliable than other tests available in the US.

Published on: